NEW Blog Post - Advancing CAR-NK Therapy: Why Leukopak Quality and Donor Characterization Matter
Discovery Partners with PathAI to Develop First AI-Powered Biospecimen Solutions
NEW Blog Post - Overcoming In Vitro Liver Metabolism Screening Limitations with Permeabilized Human Hepatocytes
Discovery Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con
NEW Blog Post - Advancing CAR-NK Therapy: Why Leukopak Quality and Donor Characterization Matter
Discovery Partners with PathAI to Develop First AI-Powered Biospecimen Solutions
NEW Blog Post - Overcoming In Vitro Liver Metabolism Screening Limitations with Permeabilized Human Hepatocytes
Discovery Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con